Hematologic toxicities predominated among treatment-related adverse events, with leukopenia, neutropenia, lymphopenia, anemia, thrombocytopenia, and transaminase elevation (ALT/AST) being most frequently observed. This evidence concerns the gene GPT and neutropenia.